Prof. S.A. Serik, PHD V.I. Strona
National Institute of Therapy. L.T. Malaya NAMS of Ukraine, Kharkiv
The article summarizes the main clinical and theoretical data on features of atrial fibrillation (AF) course in combination with diabetes mellitus (DM). The potential relationship between these comorbid conditions is analyzed on the basis of the results of epidemiological and randomized studies, the gender features of the course of AF in this category of patients are assessed. Particular attention is paid to pathogenetic bases of AF development in DM (fibrosis, neurohumoral regulation, impaired energy metabolism of cardiomyocytes, oxidative stress, genetic factors, electrolyte metabolism disorders).
Key Words: diabetes mellitus, atrial fibrillation, risk factors, atrial fibrosis, autonomic regulation, connexin.
https://dx.doi.org/10.15407/internalmed2021.02.103
Download.PDF (rus)
Cite:
- Серик, С.А. Фибрилляция предсердий у больных сахарным диабетом / С.А. Серик, В.И. Строна // Східноєвропейський журнал внутрішньої та сімейної медицини. – 2021. – № 2. – С. 103-117. doi: 15407/internalmed2021.02.103
- Serik SA, Strona VI. Fibrillyaciya predserdij u bol’nykh sakharnym diabetom. [Atrial fibrillation in diabetic patients]. Shidnoevr. z. vnutr. simejnoi med. 2021;2:103-117. Russian. doi: 10.15407/internalmed2021.02.103
References:
- World Health Organization. The World health report: 1998 : Life in the 21st century : a vision for all : report of the Director-General. World Health Organization. Availablefrom: https://apps.who.int/iris/handle/10665/42065.
- Global’nyj doklad po diabetu [Global report on diabetes]. Zheneva: Vsemirnaja organizacija zdravoohranenija; 2018. Licenzija: CC BY-NC-SA 3.0 IGO. Russian
- IDF Diabetes atlas. Ninth edition 2019. Available from: https://nonews.co/wp-content/uploads/2020/08/IDF2019. pdf
- Martín-Timón I. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?. World Journal of Diabetes. 2014;5(4):444. http://dx.doi.org/10.4239/wjd.v5.i4.444
- Belovol A.N., Knjaz’kova I.I. Serdechno-sosudistye zabolevanija i saharnyj diabet // Zdorov’ja Ukraї 2014;3 (27):28—29. Russian
- Einarson T, Acs A, Ludwig C, Panton U. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovascular Diabetology. 2018;17(1):. http://dx.doi.org/10.1186/s12933-018-0728-6
- Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical Epidemiology. 2014;:213. http://dx.doi.org/10.2147/clep.s47385
- Chugh S, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin E, Gillum R, Kim Y, McAnulty J, Zheng Z, Forouzanfar M, Naghavi M, Mensah G, Ezzati M, Murray C. Worldwide Epidemiology of Atrial Fibrillation. Circulation. 2014;129(8):837-847. http://dx.doi.org/10.1161/circulationaha.113.005119
- Kannel W, Benjamin E. Status of the Epidemiology of Atrial Fibrillation. Medical Clinics of North America. 2008;92(1):17-40. http://dx.doi.org/10.1016/j.mcna.2007.09.002
- Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. Journal of Diabetes and its Complications. 2018;32(5):501-511. http://dx.doi.org/10.1016/j.jdiacomp.2018.02.004
- Díez-Villanueva P, Alfonso F. Atrial fibrillation in the elderly. J Geriatr Cardiol. 2019; 16(1):49-53.
- Ball J, Carrington M, McMurray J, Stewart S. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st century. International Journal of Cardiology. 2013;167(5):1807-1824. http://dx.doi.org/10.1016/j.ijcard.2012.12.093
- Karamichalakis N, Letsas K, Vlachos K. Managing atrial fibrillation in the very elderly patient: challenges and solutions. Vasc Health Risk Manag. 2015;27:555-562. https://doi.org/10.2147/VHRM.S83664
- Kannel W, Wolf P, Benjamin E, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available. The American Journal of Cardiology. 1998;82(7):2N-9N. http://dx.doi.org/10.1016/s0002-9149(98)00583-9
- Stroke Prevention in Atrial Fibrillation Study. Final results. Circulation. 1991;84(2):527-539. http://dx.doi.org/10.1161/01.cir.84.2.527
- Aleksandrov AA, Jadrihinskaja MN, Abdalkina EN, Kuharenko SS, Shackaja OA. Mercatel’naja aritmija i saharnyj diabet: terapija preduprezhdenija. Lechashhij vrach. 2013;119-126. Russian
- Benjamin E. Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort. JAMA. 1994;271(11):840. http://dx.doi.org/10.1001/jama.1994.03510350050036
- Schnabel R, Yin X, Gona P, Larson M, Beiser A, McManus D, Newton-Cheh C, Lubitz S, Magnani J, Ellinor P, Seshadri S, Wolf P, Vasan R, Benjamin E, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154-162. http://dx.doi.org/10.1016/s0140-6736(14)61774-8
- Bretón-Romero R, Wang N, Palmisano J, Larson M, Vasan R, Mitchell G, Benjamin E, Vita J, Hamburg N. Cross-Sectional Associations of Flow Reversal, Vascular Function, and Arterial Stiffness in the Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2016;36(12):2452-2459. http://dx.doi.org/10.1161/atvbaha.116.307948
- Krahn A, Manfreda J, Tate R, Mathewson F, Cuddy T. The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study. The American Journal of Medicine. 1995;98(5):476-484. http://dx.doi.org/10.1016/s0002-9343(99)80348-9
- Movahed M, Hashemzadeh M, Mazen Jamal M. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. International Journal of Cardiology. 2005;105(3):315-318. http://dx.doi.org/10.1016/j.ijcard.2005.02.050
- Dublin S, Glazer N, Smith N, Psaty B, Lumley T, Wiggins K, Page R, Heckbert S. Diabetes Mellitus, Glycemic Control, and Risk of Atrial Fibrillation. Journal of General Internal Medicine. 2010;25(8):853-858. http://dx.doi.org/10.1007/s11606-010-1340-y
- Huxley R, Filion K, Konety S, Alonso A. Meta-Analysis of Cohort and Case–Control Studies of Type 2 Diabetes Mellitus and Risk of Atrial Fibrillation. The American Journal of Cardiology. 2011;108(1):56-62. http://dx.doi.org/10.1016/j.amjcard.2011.03.004
- Kyselov S. Main principles of evidence-based medicine: tutorial. Zaporizhzhia: ZSMU; 2020. 105 p.
- Huxley R, Alonso A, Lopez F, Filion K, Agarwal S, Loehr L, Soliman E, Pankow J, Selvin E. Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study. Heart. 2011;98(2):133-138. http://dx.doi.org/10.1136/heartjnl-2011-300503
- Schoen T, Pradhan A, Albert C, Conen D. Type 2 Diabetes Mellitus and Risk of Incident Atrial Fibrillation in Women. Journal of the American College of Cardiology. 2012;60(15):1421-1428. http://dx.doi.org/10.1016/j.jacc.2012.06.030
- Perez M, Wang P, Larson J, Soliman E, Limacher M, Rodriguez B, Klein L, Manson J, Martin L, Prineas R, Connelly S, Hlatky M, Wassertheil-Smoller S, Stefanick M. Risk factors for atrial fibrillation and their population burden in postmenopausal women: the Women’s Health Initiative Observational Study. Heart. 2013;99(16):1173-1178. http://dx.doi.org/10.1136/heartjnl-2013-303798
- Son M, Lim N, Cho M, Park H. Incidence and Risk Factors for Atrial Fibrillation in Korea: the National Health Insurance Service Database (2002–2010). Korean Circulation Journal. 2016;46(4):515. http://dx.doi.org/10.4070/kcj.2016.46.4.515
- Pallisgaard J, Schjerning A, Lindhardt T, Procida K, Hansen M, Torp-Pedersen C, Gislason G. Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study. European Journal of Preventive Cardiology. 2015;23(6):621-627. http://dx.doi.org/10.1177/2047487315599892
- Xiong Z, Liu T, Tse G, Gong M, Gladding P, Smaill B, Stiles M, Gillis A, Zhao J. A Machine Learning Aided Systematic Review and Meta-Analysis of the Relative Risk of Atrial Fibrillation in Patients With Diabetes Mellitus. Frontiers in Physiology. 2018;9:. http://dx.doi.org/10.3389/fphys.2018.00835
- Grundvold I, Bodegard J, Nilsson P, Svennblad B, Johansson G, Östgren C, Sundström J. Body weight and risk of atrial fibrillation in 7,169 patients with newly diagnosed type 2 diabetes; an observational study. Cardiovascular Diabetology. 2015;14(1):5. http://dx.doi.org/10.1186/s12933-014-0170-3
- Dahlqvist S, Rosengren A, Gudbjörnsdottir S, Pivodic A, Wedel H, Kosiborod M, Svensson A, Lind M. Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study. The Lancet Diabetes & Endocrinology. 2017;5(10):799-807. http://dx.doi.org/10.1016/s2213-8587(17)30262-0
- Aune D, Feng T, Schlesinger S, Janszky I, Norat T, Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. Journal of Diabetes and its Complications. 2018;32(5):501-511. http://dx.doi.org/10.1016/j.jdiacomp.2018.02.004
- Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. New England Journal of Medicine. 2010;362(16):1477-1490. http://dx.doi.org/10.1056/nejmoa1001121
- Duckworth W, Abraira C, Moritz T. Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes. Journal of Vascular Surgery. 2009;49(4):1084. http://dx.doi.org/10.1016/j.jvs.2009.02.026
- Effects of Intensive Glucose Lowering in Type 2 Diabetes. New England Journal of Medicine. 2008;358(24):2545-2559. http://dx.doi.org/10.1056/nejmoa0802743
- Klimontov VV. Vlijanie variabel’nosti glikemii na risk razvitija serdechno-sosudistyh oslozhnenij pri saharnom diabete. Kardiologija. 2018;58(10):80-87. Russian
- Chow E, Bernjak A, Williams S, Fawdry R, Hibbert S, Freeman J, Sheridan P, Heller S. Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk. Diabetes. 2014;63(5):1738-1747. http://dx.doi.org/10.2337/db13-0468
- Mellbin L, Rydén L, Riddle M, Probstfield J, Rosenstock J, Díaz R, Yusuf S, Gerstein H. Does hypoglycaemia increase the risk of cardiovascular events? A report from the ORIGIN trial. European Heart Journal. 2013;34(40):3137-3144. http://dx.doi.org/10.1093/eurheartj/eht332
- Pochinka IG, Strongin LG, Struchkova JuV. Variabel’nost’ glikemii i zheludochkovye narushenija ritma u bol’nyh hronicheskoj serdechnoj nedostatochnost’ju, stradajushhih saharnym diabetom 2-go tipa. Kardiologija. 2013; 53 (9):47—51. Russian
- Saito S, Teshima Y, Fukui A, Kondo H, Nishio S, Nakagawa M, Saikawa T, Takahashi N. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats. Cardiovascular Research. 2014;104(1):5-14. http://dx.doi.org/10.1093/cvr/cvu176
- Fatemi O, Yuriditsky E, Tsioufis C, Tsachris D, Morgan T, Basile J, Bigger T, Cushman W, Goff D, Soliman E, Thomas A, Papademetriou V. Impact of Intensive Glycemic Control on the Incidence of Atrial Fibrillation and Associated Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). The American Journal of Cardiology. 2014;114(8):1217-1222. http://dx.doi.org/10.1016/j.amjcard.2014.07.045
- Stahn A, Pistrosch F, Ganz X, Teige M, Koehler C, Bornstein S, Hanefeld M. Relationship Between Hypoglycemic Episodes and Ventricular Arrhythmias in Patients With Type 2 Diabetes and Cardiovascular Diseases: Silent Hypoglycemias and Silent Arrhythmias. Diabetes Care. 2013;37(2):516-520. http://dx.doi.org/10.2337/dc13-0600
- Kolesnik M. Fibrilljacija predserdij i soputstvujushhaja patologija: vybor pravil’noj taktiki terapii.-//Ukraїns’kij medichnij chasopis.-2019;7. Available from https://www.umj.com.ua/wp/wp-content/uploads/2019/07/ AF.pdf?upload=. Russian
- Magnussen C, Ojeda F, Schnabel R. Response by Magnussen et al to Letter Regarding Article, “Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)”. Circulation. 2018;137(19):2087-2088. http://dx.doi.org/10.1161/circulationaha.118.033968
- Onuchina ЕL, Solov’ev OV, Onuchin SG. Gendernye osobennosti razvitija fibrilljacii predserdij u pacientov s saharnym diabetom 2 tipa. Klinicheskaja medicina.2012#; 9(65). Available from URL: https://cyberleninka.ru/article/n/gendernye-osobennostirazvitiya-fibrillyatsii-predserdiy-u-patsientov-s-saharnymdiabetom-2-tipa. Russian
- Peters S, Huxley R, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes. The Lancet. 2014;383(9933):1973-1980. http://dx.doi.org/10.1016/s0140-6736(14)60040-4
- Grigorjan SV, Azarapetjan LG, Adamjan KG. Miokardial’nyj fibroz i fibrilljacija predserdij. Rossijskij kardiologicheskij zhurnal. 2018;9:71-76. Russian
- Camm A, Lip G, De Caterina R. Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation—developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33:2719-2747.
- Harada M, Nattel S. Implications of Inflammation and Fibrosis in Atrial Fibrillation Pathophysiology. Cardiac Electrophysiology Clinics. 2021;13(1):25-35. http://dx.doi.org/10.1016/j.ccep.2020.11.002
- Tadic M, Cuspidi C. Type 2 diabetes mellitus and atrial fibrillation: From mechanisms to clinical practice. Archives of Cardiovascular Diseases. 2015;108(4):269-276. http://dx.doi.org/10.1016/j.acvd.2015.01.009
- Liu C, Liu R, Fu H, Li J, Wang X, Cheng L, Korantzopoulos P, Tse G, Li G, Liu T. Pioglitazone attenuates atrial remodeling and vulnerability to atrial fibrillation in alloxan-induced diabetic rabbits. Cardiovascular Therapeutics. 2017;35(5):e12284. http://dx.doi.org/10.1111/1755-5922.12284
- Lamberts R, Lingam S, Wang H, Bollen I, Hughes G, Galvin I, Bunton R, Bahn A, Katare R, Baldi J, Williams M, Saxena P, Coffey S, Jones P. Impaired relaxation despite upregulated calcium-handling protein atrial myocardium from type 2 diabetic patients with preserved ejection fraction. Cardiovascular Diabetology. 2014;13(1):72. http://dx.doi.org/10.1186/1475-2840-13-72
- Sedgwick B, Riches K, Bageghni S, O’Regan D, Porter K, Turner N. Investigating inherent functional differences between human cardiac fibroblasts cultured from nondiabetic and Type 2 diabetic donors. Cardiovascular Pathology. 2014;23(4):204-210. http://dx.doi.org/10.1016/j.carpath.2014.03.004
- Hutchinson K, Lord C, West T, Stewart J. Cardiac Fibroblast-Dependent Extracellular Matrix Accumulation Is Associated with Diastolic Stiffness in Type 2 Diabetes. PLoS ONE. 2013;8(8):e72080. http://dx.doi.org/10.1371/journal.pone.0072080
- Liu C, Fu H, Li J, Yang W, Cheng L, Liu T, Li G. Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. Anadolu Kardiyoloji Dergisi/The Anatolian Journal of Cardiology. 2012;:. http://dx.doi.org/10.5152/akd.2012.188
- Krishnaswamy P, Egom E, Moghtadaei M, Jansen H, Azer J, Bogachev O, Mackasey M, Robbins C, Rose R. Altered parasympathetic nervous system regulation of the sinoatrial node in Akita diabetic mice. Journal of Molecular and Cellular Cardiology. 2015;82:125-135. http://dx.doi.org/10.1016/j.yjmcc.2015.02.024
- Fiaschi T, Magherini F, Gamberi T, Lucchese G, Faggian G, Modesti A, Modesti P. Hyperglycemia and angiotensin II cooperate to enhance collagen I deposition by cardiac fibroblasts through a ROS-STAT3-dependent mechanism. Biochimica et Biophysica Acta (BBA) – Molecular Cell Research. 2014;1843(11):2603-2610. http://dx.doi.org/10.1016/j.bbamcr.2014.07.009
- Bohne L, Johnson D, Rose R, Wilton S, Gillis A. The Association Between Diabetes Mellitus and Atrial Fibrillation: Clinical and Mechanistic Insights. Frontiers in Physiology. 2019;10:. http://dx.doi.org/10.3389/fphys.2019.00135
- Schotten U, Dobrev D, Platonov P, Kottkamp H, Hindricks G. Current controversies in determining the main mechanisms of atrial fibrillation. Journal of Internal Medicine. 2016;279(5):428-438. http://dx.doi.org/10.1111/joim.12492
- Aromolaran A, Boutjdir M. Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation. Frontiers in Physiology. 2017;8:. http://dx.doi.org/10.3389/fphys.2017.00431
- Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P. Role of adipose tissue in the pathogenesis of cardiac arrhythmias. Heart Rhythm. 2016;13(1):311-320. http://dx.doi.org/10.1016/j.hrthm.2015.08.016
- Mahajan R, Lau D, Brooks A, Shipp N, Manavis J, Wood J, Finnie J, Samuel C, Royce S, Twomey D, Thanigaimani S, Kalman J, Sanders P. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. Journal of the American College of Cardiology. 2015;66(1):1-11. http://dx.doi.org/10.1016/j.jacc.2015.04.058
- Russo I, Frangogiannis N. Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. Journal of Molecular and Cellular Cardiology. 2016;90:84-93. http://dx.doi.org/10.1016/j.yjmcc.2015.12.011
- Koektuerk B, Aksoy M, Horlitz M, Bozdag-Turan I, Turan R. Role of diabetes in heart rhythm disorders. World Journal of Diabetes. 2016;7(3):45. http://dx.doi.org/10.4239/wjd.v7.i3.45
- Lancefield T, Patel S, Freeman M, Velkoska E, Wai B, Srivastava P, Horrigan M, Farouque O, Burrell L. The Receptor for Advanced Glycation End Products (RAGE) Is Associated with Persistent Atrial Fibrillation. PLOS ONE. 2016;11(9):e0161715. http://dx.doi.org/10.1371/journal.pone.0161715
- CHEN J, LI Q, DONG R, GAO H, PENG H, WU Y. The effect of the Ras homolog gene family (Rho), member A/Rho associated coiled-coil forming protein kinase pathway in atrial fibrosis of type 2 diabetes in rats. Experimental and Therapeutic Medicine. 2014;8(3):836-840. http://dx.doi.org/10.3892/etm.2014.1843
- Tarasova OS, Gajnullina DK. Rho-kinaza kak kljuchevoj uchastnik reguljacii tonusa sosudov v norme i pri sosudistyh rasstrojstvah. AG. 2017;5. Available from URL: https://cyberleninka.ru/article/n/rho-kinazakak-klyuchevoy-uchastnik-regulyatsii-tonusa-sosudov-vnorme-i-pri-sosudistyh-rasstroystvah. Russian
- Shabir S, Borisova L, Wray S, Burdyga T. Rho-kinase inhibition and electromechanical coupling in rat and guinea-pig ureter smooth muscle: Ca2+-dependent and -independent mechanisms. The Journal of Physiology. 2004;560(3):839-855. http://dx.doi.org/10.1113/jphysiol.2004.070615
- Li Y, Brayden J. Rho kinase activity governs arteriolar myogenic depolarization. Journal of Cerebral Blood Flow & Metabolism. 2016;37(1):140-152. http://dx.doi.org/10.1177/0271678×15621069
- Korzh AN. Filenko JaN. Adipokiny i serdechnososudistye zabolevanija: klinicheskoe i terapevticheskoe znachenie. Shіdnoєvropejs’kij zhurnal vnutrіshn’oї ta sіmejnoї 2020;2: 47-53. doi: 10.15407/internalmed2020.02.047. Russian
- Levelt E, Pavlides M, Banerjee R, Mahmod M, Kelly C, Sellwood J, Ariga R, Thomas S, Francis J, Rodgers C, Clarke W, Sabharwal N, Antoniades C, Schneider J, Robson M, Clarke K, Karamitsos T, Rider O, Neubauer S. Ectopic and Visceral Fat Deposition in Lean and Obese Patients With Type 2 Diabetes. Journal of the American College of Cardiology. 2016;68(1):53-63. http://dx.doi.org/10.1016/j.jacc.2016.03.597
- Vavilova TP, Pleten’ AP, Miheev RK. Biologicheskaja rol’ adipokinov kak markerov patologicheskih sostojanij .Vopr. pitanija. 2017;86(2): 5—13. Russian
- Mahajan R, Lau D, Brooks A, Shipp N, Manavis J, Wood J, Finnie J, Samuel C, Royce S, Twomey D, Thanigaimani S, Kalman J, Sanders P. Electrophysiological, Electroanatomical, and Structural Remodeling of the Atria as Consequences of Sustained Obesity. Journal of the American College of Cardiology. 2015;66(1):1-11. http://dx.doi.org/10.1016/j.jacc.2015.04.058
- Haemers P, Hamdi H, Guedj K, Suffee N, Farahmand P, Popovic N, Claus P, LePrince P, Nicoletti A, Jalife J, Wolke C, Lendeckel U, Jaïs P, Willems R, Hatem S. Atrial fibrillation is associated with the fibrotic remodelling of adipose tissue in the subepicardium of human and sheep atria. European Heart Journal. 2015;38(1):53-61. http://dx.doi.org/10.1093/eurheartj/ehv625
- Venteclef N, Guglielmi V, Balse E, Gaborit B, Cotillard A, Atassi F, Amour J, Leprince P, Dutour A, Clément K, Hatem S. Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. European Heart Journal. 2014;36(13):795-805. http://dx.doi.org/10.1093/eurheartj/eht099
- Abe I, Teshima Y, Kondo H, Kaku H, Kira S, Ikebe Y, Saito S, Fukui A, Shinohara T, Yufu K, Nakagawa M, Hijiya N, Moriyama M, Shimada T, Miyamoto S, Takahashi N. Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation. Heart Rhythm. 2018;15(11):1717-1727. http://dx.doi.org/10.1016/j.hrthm.2018.06.025
- Mascitelli L, Pezzetta F. Anti-Inflammatory Action of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers. Journal of the American College of Cardiology. 2006;47(4):889. http://dx.doi.org/10.1016/j.jacc.2005.11.032
- Fukui A, Takahashi N, Nakada C, Masaki T, Kume O, Shinohara T, Teshima Y, Hara M, Saikawa T. Role of Leptin Signaling in the Pathogenesis of Angiotensin II–Mediated Atrial Fibrosis and Fibrillation. Circulation: Arrhythmia and Electrophysiology. 2013;6(2):402-409. http://dx.doi.org/10.1161/circep.111.000104
- FUKUI A, IKEBE-EBATA Y, KONDO H, SAITO S, AOKI K, FUKUNAGA N, SHINOHARA T, MASAKI T, TESHIMA Y, TAKAHASHI N. Hyperleptinemia Exacerbates High-Fat Diet-Mediated Atrial Fibrosis and Fibrillation. Journal of Cardiovascular Electrophysiology. 2017;28(6):702-710. http://dx.doi.org/10.1111/jce.13200
- Karmazyn M, Purdham D, Rajapurohitam V, Zeidan A. Signalling mechanisms underlying the metabolic and other effects of adipokines on the heart. Cardiovascular Research. 2008;79(2):279-286. http://dx.doi.org/10.1093/cvr/cvn115
- Macheret F, Bartz T, Djousse L, Ix J, Mukamal K, Zieman S, Siscovick D, Tracy R, Heckbert S, Psaty B, Kizer J. Higher circulating adiponectin levels are associated with increased risk of atrial fibrillation in older adults. 2015;101(17):1368-1374. http://dx.doi.org/10.1136/heartjnl-2014-307015
- Agarwal S, Norby F, Whitsel E, Soliman E, Chen L, Loehr L, Fuster V, Heiss G, Coresh J, Alonso A. Cardiac Autonomic Dysfunction and Incidence of Atrial Fibrillation. Journal of the American College of Cardiology. 2017;69(3):291-299. http://dx.doi.org/10.1016/j.jacc.2016.10.059
- Kreiner G, Wolzt M, Fasching P, Leitha T, Edlmayer A, Korn A, Waldhausl W, Dudczak R. Myocardial m-[123I]Iodobenzylguanidine Scintigraphy for the Assessment of Adrenergic Cardiac Innervation in Patients With IDDM: Comparison With Cardiovascular Reflex Tests and Relationship to Left Ventricular Function. 1995;44(5):543-549. http://dx.doi.org/10.2337/diab.44.5.543
- Shurdumova MG. Patogeneticheskie predposylki jelektricheskoj nestabil’nosti miokarda u bol’nyh arterial’noj gipertenziej i saharnym diabetom. Medicinskij vestnik Juga Rossii. 2015;3:8-17. Russian
- Esler M. The autonomic nervous system and cardiac arrhythmias. Clinical Autonomic Research. 1992;2(2):133-135. http://dx.doi.org/10.1007/bf01819669
- Schauerte P, Scherlag B. Die Behandlung des tachykarden Vorhofflimmerns durch kathetergestützte elektrische Stimulation des kardialen parasympathischen Nervensystems. Zeitschrift für Kardiologie. 2000;89(9):766-773. http://dx.doi.org/10.1007/s003920070180
- Rizzo M, Sasso F, Marfella R, Siniscalchi M, Paolisso P, Carbonara O, Capoluongo M, Lascar N, Pace C, Sardu C, Passavanti B, Barbieri M, Mauro C, Paolisso G. Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. Journal of Diabetes and its Complications. 2015;29(1):88-92. http://dx.doi.org/10.1016/j.jdiacomp.2014.09.002
- Negishi K, Seicean S, Negishi T, Yingchoncharoen T, Aljaroudi W, Marwick T. Relation of Heart-Rate Recovery to New Onset Heart Failure and Atrial Fibrillation in Patients With Diabetes Mellitus and Preserved Ejection Fraction. The American Journal of Cardiology. 2013;111(5):748-753. http://dx.doi.org/10.1016/j.amjcard.2012.11.028
- Singh J, Larson M, O’Donnell C, Wilson P, Tsuji H, Lloyd-Jones D, Levy D. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). The American Journal of Cardiology. 2000;86(3):309-312. http://dx.doi.org/10.1016/s0002-9149(00)00920-6
- Cheng Y, Lauer M, Earnest C, Church T, Kampert J, Gibbons L, Blair S. Heart Rate Recovery Following Maximal Exercise Testing as a Predictor of Cardiovascular Disease and All-Cause Mortality in Men With Diabetes. Diabetes Care. 2003;26(7):2052-2057. http://dx.doi.org/10.2337/diacare.26.7.2052
- Bissinger A, Grycewicz T, Grabowicz W, Lubinski A. The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation. Archives of Medical Science. 2011;5:806-812. http://dx.doi.org/10.5114/aoms.2011.25555
- Chow E, Bernjak A, Walkinshaw E, Lubina-Solomon A, Freeman J, Macdonald I, Sheridan P, Heller S. Cardiac Autonomic Regulation and Repolarization During Acute Experimental Hypoglycemia in Type 2 Diabetes. Diabetes. 2017;66(5):1322-1333. http://dx.doi.org/10.2337/db16-1310
- Franz M, Jamal S, Narayan S. The role of action potential alternans in the initiation of atrial fibrillation in humans: a review and future directions. EP Europace. 2012;14(suppl_5):58-64. http://dx.doi.org/10.1093/europace/eus273
- Zhang Q, Liu T, Ng C, Li G. Diabetes Mellitus and Atrial Remodeling: Mechanisms and Potential Upstream Therapies. Cardiovascular Therapeutics. 2014;32(5):233-241. http://dx.doi.org/10.1111/1755-5922.12089
- Sperelakis N. Fiziologija i patofiziologija serdca. Medicina, 2015. T. 2. 623 р. Russian
- Jakovleva LN. Osobye sostojanija miokarda pri ishemii. Lіki Ukraїni. 2018.;2(218):43-48. Russian
- Mora M, Ferrero J, Gomez J, Sobie E, Trenor B. Ca2+ Cycling Impairment in Heart Failure Is Exacerbated by Fibrosis: Insights Gained From Mechanistic Simulations. Frontiers in Physiology. 2018;9:. http://dx.doi.org/10.3389/fphys.2018.01194
- Majljan DJe, Kolomiec V V. Rol’ dismetabolizma kal’cija v patogeneze serdechno-sosudistyh zabolevanij . 2019;24(9):78-85. Russian
- Singh R, Cummings E, Pantos C, Singh J. Protein kinase C and cardiac dysfunction: a review. Heart Failure Reviews. 2017;22(6):843-859. http://dx.doi.org/10.1007/s10741-017-9634-3
- Paolisso G, Gualdiero P, Manzella D, Rizzo M, Tagliamonte M, Gambardella A, Verza M, Gentile S, Varricchio M, D’Onofrio F. Association of Fasting Plasma Free Fatty Acid Concentration and Frequency of Ventricular Premature Complexes in Nonischemic Non-Insulin-Dependent Diabetic Patients. The American Journal of Cardiology. 1997;80(7):932-937. http://dx.doi.org/10.1016/s0002-9149(97)00548-1
- Samman Tahhan A, Sandesara P, Hayek S, Alkhoder A, Chivukula K, Hammadah M, Mohamed-Kelli H, O’Neal W, Topel M, Ghasemzadeh N, Ko Y, Aida H, Gafeer M, Sperling L, Vaccarino V, Liang Y, Jones D, Quyyumi A. Association between oxidative stress and atrial fibrillation. Heart Rhythm. 2017;14(12):1849-1855. http://dx.doi.org/10.1016/j.hrthm.2017.07.028
- Aiello E, Jabr R, Cole W. Arrhythmia and Delayed Recovery of Cardiac Action Potential During Reperfusion After Ischemia. Circulation Research. 1995;77(1):153-162. http://dx.doi.org/10.1161/01.res.77.1.153
- Rochette L, Zeller M, Cottin Y, Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochimica et Biophysica Acta (BBA) – General Subjects. 2014;1840(9):2709-2729. http://dx.doi.org/10.1016/j.bbagen.2014.05.017
- Zhang J, Youn J, Kim A, Ramirez R, Gao L, Ngo D, Chen P, Scovotti J, Mahajan A, Cai H. NOX4-Dependent Hydrogen Peroxide Overproduction in Human Atrial Fibrillation and HL-1 Atrial Cells: Relationship to Hypertension. Frontiers in Physiology. 2012;3:. http://dx.doi.org/10.3389/fphys.2012.00140
- Bonilla I, Sridhar A, Györke S, Cardounel A, Carnes C. Nitric Oxide Synthases and Atrial Fibrillation. Frontiers in Physiology. 2012;3:. http://dx.doi.org/10.3389/fphys.2012.00105
- Grisanti L. Diabetes and Arrhythmias: Pathophysiology, Mechanisms and Therapeutic Outcomes. Frontiers in Physiology. 2018;9:. http://dx.doi.org/10.3389/fphys.2018.01669
- Violi F, Pastori D, Pignatelli P, Loffredo L. Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis. Europace. 2014;16(8):1107-1116. http://dx.doi.org/10.1093/europace/euu040
- Mesubi O, Anderson M. Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signal. Cardiovascular Research. 2016;109(4):542-557. http://dx.doi.org/10.1093/cvr/cvw002
- Purohit A, Rokita A, Guan X, Chen B, Koval O, Voigt N, Neef S, Sowa T, Gao Z, Luczak E, Stefansdottir H, Behunin A, Li N, El-Accaoui R, Yang B, Swaminathan P, Weiss R, Wehrens X, Song L, Dobrev D, Maier L, Anderson M. Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation. 2013;128(16):1748-1757. http://dx.doi.org/10.1161/circulationaha.113.003313
- Jain S, Paglialunga S, Vigna C, Ludzki A, Herbst E, Lally J, Schrauwen P, Hoeks J, Tupling A, Bonen A, Holloway G. High-Fat Diet–Induced Mitochondrial Biogenesis Is Regulated by Mitochondrial-Derived Reactive Oxygen Species Activation of CaMKII. 2014;63(6):1907-1913. http://dx.doi.org/10.2337/db13-0816
- Erickson J, Pereira L, Wang L, Han G, Ferguson A, Dao K, Copeland R, Despa F, Hart G, Ripplinger C, Bers D. Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. 2013;502(7471):372-376. http://dx.doi.org/10.1038/nature12537
- Luo M, Guan X, Luczak E, Lang D, Kutschke W, Gao Z, Yang J, Glynn P, Sossalla S, Swaminathan P, Weiss R, Yang B, Rokita A, Maier L, Efimov I, Hund T, Anderson M. Diabetes increases mortality after myocardial infarction by oxidizing CaMKII. Journal of Clinical Investigation. 2013;123(3):1262-1274. http://dx.doi.org/10.1172/jci65268
- Zhong P, Quan D, Huang Y, Huang H. CaMKII Activation Promotes Cardiac Electrical Remodeling and Increases the Susceptibility to Arrhythmia Induction in High-fat Diet–Fed Mice With Hyperlipidemia Conditions. Journal of Cardiovascular Pharmacology. 2017;70(4):245-254. http://dx.doi.org/10.1097/fjc.0000000000000512
- Sychjov OS, Mihaleva TV, Talaeva TV. Allel’nyj polimorfizm gena konneksina-40 (rs10465885) u pacientov s fibrilljaciej predserdij neklapannogo geneza. Ukrainskij kardiologicheskij zhurnal. 2014;1:27-39. Russian
- Andreasen L, Nielsen J, Olesen M. Genetic Aspects of Lone Atrial Fibrillation: What Do We Know?. Current Pharmaceutical Design. 2014;21(5):667-678. http://dx.doi.org/10.2174/1381612820666140825143610
- Nattel S, Harada M. Atrial Remodeling and Atrial Fibrillation. Journal of the American College of Cardiology. 2014;63(22):2335-2345. http://dx.doi.org/10.1016/j.jacc.2014.02.555
- dos Santos D, Blefari V, Prado F, Silva C, Fazan R, Salgado H, Ramos S, Prado C. Reduced expression of adherens and gap junction proteins can have a fundamental role in the development of heart failure following cardiac hypertrophy in rats. Experimental and Molecular Pathology. 2016;100(1):167-176. http://dx.doi.org/10.1016/j.yexmp.2015.12.009
- Kato T, Iwasaki Y, Nattel S. Connexins and Atrial Fibrillation. Circulation. 2012;125(2):203-206. http://dx.doi.org/10.1161/circulationaha.111.075432
- Watanabe M, Yokoshiki H, Mitsuyama H, Mizukami K, Ono T, Tsutsui H. Conduction and refractory disorders in the diabetic atrium. American Journal of Physiology-Heart and Circulatory Physiology. 2012;303(1):H86-H95. http://dx.doi.org/10.1152/ajpheart.00010.2012
- Hage C, Michaëlsson E, Linde C, Donal E, Daubert J, Gan L, Lund L. Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction. Circulation: Cardiovascular Genetics. 2017;10(1):. http://dx.doi.org/10.1161/circgenetics.116.001633
- Hanif W, Alex L, Su Y, Shinde A, Russo I, Li N, Frangogiannis N. Left atrial remodeling, hypertrophy, and fibrosis in mouse models of heart failure. Cardiovascular Pathology. 2017;30:27-37. http://dx.doi.org/10.1016/j.carpath.2017.06.003
- Olsen K, Axelsen L, Braunstein T, Sørensen C, Andersen C, Ploug T, Holstein-Rathlou N, Nielsen M. Myocardial impulse propagation is impaired in right ventricular tissue of Zucker Diabetic Fatty (ZDF) rats. Cardiovascular Diabetology. 2013;12(1):19. http://dx.doi.org/10.1186/1475-2840-12-19
- Veeranki S, Givvimani S, Kundu S, Metreveli N, Pushpakumar S, Tyagi S. Moderate intensity exercise prevents diabetic cardiomyopathy associated contractile dysfunction through restoration of mitochondrial function and connexin 43 levels in db/db mice. Journal of Molecular and Cellular Cardiology. 2016;92:163-173. http://dx.doi.org/10.1016/j.yjmcc.2016.01.023
- Igarashi T, Finet J, Takeuchi A, Fujino Y, Strom M, Greener I, Rosenbaum D, Donahue J. Connexin Gene Transfer Preserves Conduction Velocity and Prevents Atrial Fibrillation. 2012;125(2):216-225. http://dx.doi.org/10.1161/circulationaha.111.053272
- Ferdous Z, Qureshi M, Jayaprakash P, Parekh K, John A, Oz M, Raza H, Dobrzynski H, Adrian T, Howarth F. Different Profile of mRNA Expression in Sinoatrial Node from Streptozotocin-Induced Diabetic Rat. PLOS ONE. 2016;11(4):e0153934. http://dx.doi.org/10.1371/journal.pone.0153934
- Howarth F, Parekh K, Jayaprakash P, Inbaraj E, Oz M, Dobrzynski H, Adrian T. Altered profile of mRNA expression in atrioventricular node of streptozotocin-induced diabetic rats. Molecular Medicine Reports. 2017;16(4):3720-3730. http://dx.doi.org/10.3892/mmr.2017.7038
- Sychjov OS, Mihaleva TV, Gur’janov VG, Mihalev KA. Fenotipicheskie klastery pacientov s fibrilljaciej predserdij neklapannogo geneza v vozraste do 65 let: polimorfizm rs10465885 gena konneksina-40 i klinicheskie harakteristiki aritmii. Aktual’nye problemy mediciny. 2015;16:213. Russian
- Oyen N, Ranthe M, Carstensen L, Boyd H, Olesen M, Olesen S, Wohlfahrt J, Melbye M. Familial Aggregation of Lone Atrial Fibrillation in Young Persons. Journal of the American College of Cardiology. 2012;60(10):917-921. http://dx.doi.org/10.1016/j.jacc.2012.03.046
- Weijs B, Schotten U, Crijns H. Pathophysiology of Idiopathic Atrial Fibrillation – Prognostic and Treatment Implications. Current Pharmaceutical Design. 2014;21(5):551-572. http://dx.doi.org/10.2174/1381612820666140825150057
- Darbar D, Roden D. Genetic mechanisms of atrial fibrillation: impact on response to treatment. Nature Reviews Cardiology. 2013;10(6):317-329. http://dx.doi.org/10.1038/nrcardio.2013.53
- Rienstra M, Lubitz S, Mahida S, Magnani J, Fontes J, Sinner M, Van Gelder I, Ellinor P, Benjamin E. Symptoms and Functional Status of Patients With Atrial Fibrillation. Circulation. 2012;125(23):2933-2943. http://dx.doi.org/10.1161/circulationaha.111.069450
- Liamis G. Diabetes mellitus and electrolyte disorders. World Journal of Clinical Cases. 2014;2(10):488. http://dx.doi.org/10.12998/wjcc.v2.i10.488
- Balabolkin MI, Belojarceva F. Rol’ Na+-N+ obmennika v patogeneze saharnogo diabeta 2 tipa. Saharnyj diabet. 2001;2:49-55. Russian. https://doi.org/10.14341/2072-0351-5663
- Aritmii serdca. V 3 tomah. Per. s ang. Mandela VDzh, editor. : Medicina; 1996. 512 р. Russian
- Boyle P, Zahid S, Trayanova N. Towards personalized computational modelling of the fibrotic substrate for atrial arrhythmia. EP Europace. 2016;18(suppl_4):iv136-iv145. http://dx.doi.org/10.1093/europace/euw358
- Xiong Z, Liu T, Tse G, Gong M, Gladding P, Smaill B, Stiles M, Gillis A, Zhao J. A Machine Learning Aided Systematic Review and Meta-Analysis of the Relative Risk of Atrial Fibrillation in Patients With Diabetes Mellitus. Frontiers in Physiology. 2018;9:. http://dx.doi.org/10.3389/fphys.2018.00835
- Grandi E, Maleckar M. Anti-arrhythmic strategies for atrial fibrillation. Pharmacology & Therapeutics. 2016;168:126-142. http://dx.doi.org/10.1016/j.pharmthera.2016.09.012